Zhuhai Rundu Pharmaceutical Co., Ltd. (SHE:002923)

SHE:002923 Revenue

Zhuhai Rundu Pharmaceutical had revenue of 360.18M CNY in the quarter ending June 30, 2026, with 22.78% growth. This brings the company's total for the last twelve months to 1.34B, up 17.99% year-over-year. In the year 2025, Zhuhai Rundu Pharmaceutical had annual revenue of 1.18B, down -0.51%. That makes Zhuhai Rundu Pharmaceutical the 17,469th largest company in the world by revenue and 3,177th in China.

• Revenue (ttm): 1.34B
• Revenue Growth: +17.99%
• P/S Ratio: 2.29
• Revenue / Employee: 807.96K
• Employees: 1,655
• Market Cap: 3.06B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Chemical Pharmaceutical Manufacturing 649.46M 55.2%
• Manufacturing of Active Pharmaceutical Ingredients 508.82M 43.3%
• Unallocated Other Operations 18.08M 1.5%

By Geography

Chart

• East China 325.59M 27.7%
• South China 235.87M 20.1%
• Central China 179.15M 15.2%
• Export 173.66M 14.8%
• Southwest China 131.18M 11.2%
• North China 72.29M 6.1%
• Northwest China 44.08M 3.7%
• Northeast 14.54M 1.2%

Fiscal year ended Dec 31, 2025 See the full SHE:002923 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.18B	-6.00M	-0.51%
Dec 31, 2024	1.18B	-109.52M	-8.48%
Dec 31, 2023	1.29B	-80.35M	-5.86%
Jan 1, 2023	1.37B	182.31M	15.32%
Jan 1, 2022	1.19B	-62.70M	-5.01%

Data Source: S&P Global Market Intelligence Last updated: Aug 20, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 24, 2026

Data Sources Report a data error